See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.44▲ 3.99%
← M7U page
XStocksXray
Market X-Ray report · 23 October 2026

Nynomic AG (M7U)

XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026

Key indicators

Last closeEUR 23.20
52-week range8.22 – 28.40
Return, 1 month / 3 months−6.1% / +40.6%
Return, 1 year / 3 years+122.0% / −17.7%
TrendAbove 200-day, below 50-day
RSI (14)44
Volatility (1 year)80.5%
Worst drawdown (1 year)-44.5%
Average daily value traded0.54M EUR
Dividend yield–

Market X-Ray price-based

64/ 100 · High confidence · ahead of 74% of stocks on this exchange
Trend84
Momentum91
Stability (higher is calmer)16
Liquidity66
Income–

Five-year price chart navy: price · brown: 200-day average

5.9117.3428.7840.2251.652021-112023-012024-042025-072026-10

About the company

Nynomic AG is a German photonics group that develops and makes optical measurement and sensor systems. Its businesses supply instruments and components used for spectroscopy, thin-film measurement, machine vision and automation, serving industrial manufacturers, laboratories and life science customers. The company is based in Germany and sells its products to customers in several countries through its operating subsidiaries and their brands.

On this site Nynomic AG appears as a stock on the XETRA Stock Exchange (Germany), code M7U, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Nynomic AG (M7U) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 23.20 on 23 October 2026.

Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 182 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 122.0% and over the last three months it rose 40.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Nynomic AG (M7U)

The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange

Lens and metricValueScoreReading
Trend84 · StrongTrading above its long-term averages and near its highs.
Above 200-day average32.8%
From 52-week high-17.4%
Momentum91 · StrongRising faster than most stocks on this exchange.
3-month return40.6%
6-month return17.2%
12-month return, skipping the last month136.4%
Stability (higher is calmer)16 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)80.5%
Worst drawdown, 1 year (smaller is calmer)-44.5%
Liquidity66 · FairModerate trading activity.
Average daily value traded0.54M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−3.3%
1 month−6.1%
3 months+40.6%
6 months+17.2%
1 year+122.0%
3 years−17.7%
5 years−48.4%

Signals

50-day / 200-day average23.95 / 17.47
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.45

Technical summary

DailyBearish5 bullish · 3 neutral · 8 bearish
WeeklyStrongly bullish9 bullish · 1 neutral · 2 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026